Literature DB >> 9316530

Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting.

S D Anker1, A L Clark, M Kemp, C Salsbury, M M Teixeira, P G Hellewell, A J Coats.   

Abstract

OBJECTIVES: We sought to assess the possible relations between clinical severity of chronic heart failure and catabolic factors, specifically tumor necrosis factor (TNF), soluble TNF receptors 1 and 2 (sTNFR-1 and sTNFR-2), cortisol, testosterone and dehydroepiandrosterone (DHEA).
BACKGROUND: Chronic heart failure is associated with loss of muscle bulk that may be related to alteration of the balance between catabolism and anabolism.
METHODS: Sixty-three patients (average age +/- SD 60.4 +/- 11.3 years) with stable chronic heart failure and 20 control subjects aged 52.8 +/- 11.4 years were studied. We measured body mass index (BMI) and obtained maximal incremental exercise testing with metabolic gas exchange measurements and measurements of venous levels of TNF, sTNFR-1 and sTNFR-2, cortisol and DHEA.
RESULTS: There was no difference in total TNF-alpha levels between patients and control subjects (9.76 +/- 8.59 vs. 6.84 +/- 2.7 pg/ml). sTNFR-1 (128.9 +/- 84.5 vs. 63.6 +/- 23.3 pg/ml, p < 0.003) and sTNFR-2 (250.1 +/- 109.5 vs. 187.9 +/- 92.2 pg/ml, p = 0.03) were higher in patients. DHEA was lower in patients (9.88 +/- 6.94 vs. 15.64 +/- 8.33 nmol/liter, p = 0.004). The ratio of log cortisol to log DHEA correlated with log TNF level (r = 0.50, p < 0.001 for the patients alone; r = 0.48, p < 0.001 for the group as a whole). Peak oxygen consumption correlated with both sTNFR-1 and sTNFR-2 (r = -0.51, p < 0.001 and r = -0.39, p < 0.001, respectively). There was a negative correlation between BMI and TNF levels (r = -0.43, p < 0.001 for the patients) and the cortisol/DHEA ratio (r = -0.32, p = 0.01 for the patients).
CONCLUSIONS: There is an increase in TNF and its soluble receptors in chronic heart failure. This increase is associated with a rise in the cortisol/DHEA (catabolic/anabolic) ratio. These changes correlate with BMI and clinical severity of heart failure, suggesting a possible etiologic link.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9316530     DOI: 10.1016/s0735-1097(97)00262-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  37 in total

Review 1.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

Review 2.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

3.  Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation.

Authors:  Michael J Toth; Martin M LeWinter; Philip A Ades; Dwight E Matthews
Journal:  Clin Sci (Lond)       Date:  2010-08-17       Impact factor: 6.124

Review 4.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

5.  Roles of ghrelin in left-ventricular remodelling after acute myocardial infarction.

Authors:  Hideyuki Kondo; Yukihiro Hojo; Nozomu Takahashi; Tomokazu Ikemoto; Hirotaka Aoki; Katsuya Dezaki; Kazuomi Kario; Takaaki Katsuki; Toshihiko Yada; Kazuyuki Shimada
Journal:  Heart Asia       Date:  2010-07-05

6.  Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study.

Authors:  Marcello Maggio; Fulvio Lauretani; Gian Paolo Ceda; Stefania Bandinelli; Shari M Ling; E Jeffrey Metter; Andrea Artoni; Laura Carassale; Anna Cazzato; Graziano Ceresini; Jack M Guralnik; Shehzad Basaria; Giorgio Valenti; Luigi Ferrucci
Journal:  Arch Intern Med       Date:  2007-11-12

Review 7.  Heart failure: What causes the symptoms of heart failure?

Authors:  A J Coats
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

Review 8.  Cachexia in chronic heart failure: endocrine determinants and treatment perspectives.

Authors:  Norman Mangner; Yae Matsuo; Gerhard Schuler; Volker Adams
Journal:  Endocrine       Date:  2012-08-19       Impact factor: 3.633

Review 9.  Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.

Authors:  Georgios Tzanis; Stavros Dimopoulos; Varvara Agapitou; Serafim Nanas
Journal:  Curr Heart Fail Rep       Date:  2014-03

10.  An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.

Authors:  Estelle Lach-Trifilieff; Giulia C Minetti; KellyAnn Sheppard; Chikwendu Ibebunjo; Jerome N Feige; Steffen Hartmann; Sophie Brachat; Helene Rivet; Claudia Koelbing; Frederic Morvan; Shinji Hatakeyama; David J Glass
Journal:  Mol Cell Biol       Date:  2013-12-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.